Put Options Transactions Made in Q4 2023 in Travere Therapeutics, Inc. (TVTX)
This table provides information about the institutional ownership of Travere Therapeutics, Inc. (TVTX) during Q4 2023. The information is specifically focused on institutions that hold put options of Travere Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 15, 2024
Q4 2023
|
Barclays PLC
London, X0 |
BUY
|
PUT |
168KNew |
$914K - $1.6M
|
168K
$3.92M
|
|
|
Feb 14, 2024
Q4 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
BUY
|
PUT |
14.1K+ 21.59% |
$76.7K - $134K
|
79.4K
$1.85M
|
|
|
Feb 01, 2024
Q4 2023
|
Wolverine Asset Management LLC
|
SELL
|
PUT |
-900- 5.2% |
$4.9K - $8.55K
|
16.4K
$383K
|
|
|
Feb 14, 2024
Q4 2023
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
SELL
|
PUT |
-20.4K- 36.23% |
$111K - $194K
|
35.9K
$838K
|
|
|
Feb 09, 2024
Q4 2023
|
Ubs Group Ag
|
SELL
|
PUT |
-71.9K- 51.58% |
$391K - $683K
|
67.5K
$1.57M
|